Tag

Market Forecasts

All articles tagged with #market forecasts

Chip Crunch Set to Raise Your Next Smartphone’s Price in 2026
market-news3 days ago

Chip Crunch Set to Raise Your Next Smartphone’s Price in 2026

A memory-chip shortage driven by surging AI data-center demand is lifting storage and memory costs, triggering pricing pressure across devices in 2026. Nothing’s Carl Pei warns of 30%+ price hikes on some models, and Samsung hints at repricing; Dell and HP signaled 15–20% increases in the near term. IDC expects smartphone prices to rise 3–8% and PC prices 4–8%, with global device shipments potentially down about 9%. TrendForce also projects reduced smartphone production, while larger brands may gain share as smaller players struggle.}

2024 Market Predictions: Wall Street Oracles Forecast Stock Market's Next Move
finance2 years ago

2024 Market Predictions: Wall Street Oracles Forecast Stock Market's Next Move

The year 2023 brought unexpected outcomes for financial markets and the US economy, with no recession materializing and regional banks failing due to exposure to long-term securities. Wall Street oracles who accurately predicted these events include Bill Martin, who shorted Silicon Valley Bank's stock, and Manan Gosalia, who had a bearish rating on several banks. Additionally, economists Jan Hatzius, Ellen Zentner, Neil Dutta, and Marko Papic correctly forecasted that there would be no recession in 2023. The S&P 500 outperformed expectations, rallying 23% after a 20% decline in 2022, with Tom Lee being one of the analysts who predicted its strong performance.

"Wall Street's Skyrocketing Forecasts: Anti-Obesity Drug Sales Set to Surpass $100 Billion"
healthcare2 years ago

"Wall Street's Skyrocketing Forecasts: Anti-Obesity Drug Sales Set to Surpass $100 Billion"

Wall Street analysts are raising their forecasts for the sales of anti-obesity drugs, such as Wegovy and Mounjaro, with estimates ranging from $71 billion to $200 billion by 2035. Guggenheim analyst Seamus Fernandez believes that GLP-1-based incretins will become the most prescribed drugs ever by 2031, with potential benefits for cardiovascular health, sleep apnea, and chronic kidney disease. Citi's forecast is more conservative, assuming a smaller patient population opting for the drugs. Despite high prices and limited insurance coverage, analysts expect these issues to be resolved over time, leading to peak sales of around $100 billion by 2030. Eli Lilly, which sells Mounjaro, is expected to capture a significant portion of this market.